Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli | BMC Biotechnology | Full Text
Characterization of Tissue Plasminogen Activator Expression and Trafficking in the Adult Murine Brain | eNeuro
Fig. S4. Effects of excess tPA on synaptic markers in the molecular... | Download Scientific Diagram
Tissue plasminogen activator - Wikipedia
Serum markers CASA, CEA, CYFRA 21-1, MSA, NSE, TPA and TPS in lung cancer
AFP, CEA, CA 19-9 and TPA in Hepatocellular Carcinoma
Anti-Tissue Plasminogen Activator antibody (ab62763) | Abcam
Involvement of Tissue Plasminogen Activator in Onset and Effector Phases of Experimental Allergic Encephalomyelitis | Journal of Neuroscience
Immunocytochemical detection of dopaminergic markers in RA/TPA... | Download Scientific Diagram
Table 1 from Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar
High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer - Gynecologic Oncology
Mouse tPA Active Recombinant – Innovative Research
Histological analysis of inflammatory cell infiltration in the DMBA-TPA... | Download Scientific Diagram
Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats | PLOS ONE
Human tPA Purified Non-Cleavable – Innovative Research
TPA prevents the expression of differentiation markers during the... | Download Scientific Diagram
t-Plasminogen Activator/tPA Antibodies: Novus Biologicals
Preliminary Studies to Compare Sensitivity of Tissue Polypeptide Antigen ( TPA) with Carcinoembryonic Antigen (CEA) as Universal
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disorders
t-Plasminogen Activator/tPA Antibodies: Novus Biologicals
Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. - Abstract - Europe PMC
